The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s self-injections market report forecasts the self-injections market size to grow to $117.26 Billion by 2027, with a CAGR (compound annual growth rate) of more than 23%.

Learn More On The Self-Injections Market Report 2023 – https://www.thebusinessresearchcompany.com/report/self-injections-global-market-report

Self-Injections Market Size Forecast
The global self-injections market is expected to grow from $40.70 billion in 2022 to $51.22 billion in 2023 at a compound annual growth rate (CAGR) of 25.83%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The self injections market size is expected to reach $117.26 billion in 2027 at a CAGR of 23.01%.

North America held the largest self-injections market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Self-Injections Market Driver ­– Growth In Number Of Diabetic Patients
For instance, according to International Diabetes Federation (IDF), a Belgium-based organization that represents 230 national diabetes associations in more than 160 countries and territories, in 2021, 567 million adults aged between 20 to 79 years are currently living with diabetes, and the number of diabetic patients is expected to grow and reach 643 million by 2030 and 783 million by 2045. Therefore, the growing number of diabetic patients is driving the growth of the self-injections market.

Request for A Sample Of The Global Self-Injections Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8235&type=smp

Key Self-Injections Market Trend – Technological Advancement
Major companies in the market are concentrating on technological innovations s to sustain their position in the market. For instance, in October 2020, Aptar Pharma, a US-based drug device manufacturing company launched AdhereIT, a connected, intuitive, and user-friendly auto-injectors. This is the first fully interchangeable, auto-injectors that work across a multitude of auto-injector platforms. AdhereIT pairs a patient’s auto-injector with the existing software applications via Bluetooth technology to their mobile phone.

Self-Injections Market Segment
1) By Type: Devices, Formulations
2) By Route Of Administration: Skin, Circulatory or Musculoskeletal, Organs, Central Nervous System
3) By Dosage: Single Dose, Multi Dose
4) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
5) By Distribution Channel: Hospitals Pharmacies, Clinics, Chemist, Online Pharmacies

Self-Injections Market Major Players and Strategies
Major players in the self-injections market are AbbVie Inc., Antares Pharma Inc., Baxter International Inc., Becton, Dickinson and Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Owen Mumford Limited, PenJet Corporation, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, SHL Group, Terumo Corporation, West Pharmaceutical Services Inc., Wilhelm Haselmeier GmbH & Co. KG, Ypsomed Group, Bristol-Myers Squibb Company, Scintilla Pharmaceuticals Inc., Merck & Co. Inc., and Bayer AG.

In June 2022, Dr Reddy Labs, an India-based manufacturer of pharmaceuticals acquired an injectable portfolio from Eton Pharma for $50 million. With this acquisition, Dr. Reddy’s aimed to accelerate and expand affordable medications for patients. Also, it enters into new portfolios such as injection and recipes. Eton Pharma is a US-based manufacturer of pharmaceuticals and injections.

The Self-Injections Global Market Report 2023 covers regional data on self-injections market size, self-injections market trends and drivers, opportunities, strategies, and self-injections market competitor analysis. The countries covered in the self-injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Self-injection refers to a device used for the act of injecting oneself. Self-injections enable patients and users to administer medicines and drugs that need to be injected into them by themselves without the need for a physician or a medical professional.

View More Reports Related To The Self-Injections Market –
Joint Pain Injections Global Market Report 2023
Drugs For Erectile Dysfunction Global Market Report 2023
Antisense & RNAi Therapeutics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: